Literature DB >> 22607801

Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection.

Elizabeth B Wilson1, Yoko Kidani, Heidi Elsaesser, Jennifer Barnard, Laura Raff, Christopher L Karp, Steven Bensinger, David G Brooks.   

Abstract

During persistent viral infection, adaptive immune responses are suppressed by immunoregulatory factors, contributing to viral persistence. Although this suppression is mediated by inhibitory factors, the mechanisms by which virus-specific T cells encounter and integrate immunoregulatory signals during persistent infection are unclear. We show that a distinct population of IL-10-expressing immunoregulatory antigen-presenting cells (APCs) is amplified during chronic versus acute lymphocytic choriomeningitis virus (LCMV) infection and suppresses T cell responses. Although acute LCMV infection induces the expansion of immunoregulatory APCs, they subsequently decline. However, during persistent LCMV infection, immunoregulatory APCs are amplified and parallel the viral replication kinetics. Further characterization demonstrates that immunoregulatory APCs are molecularly and metabolically distinct, and exhibit increased expression of T cell-interacting molecules and negative regulatory factors that suppress T cell responses. Thus, immunoregulatory APCs are amplified during viral persistence and deliver inhibitory signals that suppress antiviral T cell immunity and likely contribute to persistent infection.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22607801      PMCID: PMC3359873          DOI: 10.1016/j.chom.2012.03.009

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  47 in total

Review 1.  T cells and viral persistence: lessons from diverse infections.

Authors:  Paul Klenerman; Ann Hill
Journal:  Nat Immunol       Date:  2005-09       Impact factor: 25.606

2.  Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation.

Authors:  Divya Vats; Lata Mukundan; Justin I Odegaard; Lina Zhang; Kristi L Smith; Christine R Morel; Roger A Wagner; David R Greaves; Peter J Murray; Ajay Chawla
Journal:  Cell Metab       Date:  2006-07       Impact factor: 27.287

3.  Interleukin-10 determines viral clearance or persistence in vivo.

Authors:  David G Brooks; Matthew J Trifilo; Kurt H Edelmann; Luc Teyton; Dorian B McGavern; Michael B A Oldstone
Journal:  Nat Med       Date:  2006-10-15       Impact factor: 53.440

4.  Blocking of interleukin-10 receptor--a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus.

Authors:  Eirini I Rigopoulou; William G H Abbott; Philip Haigh; Nikolai V Naoumov
Journal:  Clin Immunol       Date:  2005-10       Impact factor: 3.969

5.  Transcriptional repressor Blimp-1 regulates T cell homeostasis and function.

Authors:  Gislâine A Martins; Luisa Cimmino; Miriam Shapiro-Shelef; Matthias Szabolcs; Alan Herron; Erna Magnusdottir; Kathryn Calame
Journal:  Nat Immunol       Date:  2006-03-26       Impact factor: 25.606

6.  Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection.

Authors:  David G Brooks; Dorian B McGavern; Michael B A Oldstone
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

7.  Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection.

Authors:  Paola Agnellini; Petra Wolint; Manuela Rehr; Julia Cahenzli; Urs Karrer; Annette Oxenius
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-07       Impact factor: 11.205

8.  Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction.

Authors:  Daniel E Kaufmann; Daniel G Kavanagh; Florencia Pereyra; John J Zaunders; Elizabeth W Mackey; Toshiyuki Miura; Sarah Palmer; Mark Brockman; Almas Rathod; Alicja Piechocka-Trocha; Brett Baker; Baogong Zhu; Sylvie Le Gall; Michael T Waring; Ryan Ahern; Kristin Moss; Anthony D Kelleher; John M Coffin; Gordon J Freeman; Eric S Rosenberg; Bruce D Walker
Journal:  Nat Immunol       Date:  2007-09-30       Impact factor: 25.606

9.  Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.

Authors:  Craig L Maynard; Laurie E Harrington; Karen M Janowski; James R Oliver; Carlene L Zindl; Alexander Y Rudensky; Casey T Weaver
Journal:  Nat Immunol       Date:  2007-08-12       Impact factor: 25.606

10.  Resolution of a chronic viral infection after interleukin-10 receptor blockade.

Authors:  Mette Ejrnaes; Christophe M Filippi; Marianne M Martinic; Eleanor M Ling; Lisa M Togher; Shane Crotty; Matthias G von Herrath
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

View more
  30 in total

1.  Early induction of interleukin-10 limits antigen-specific CD4⁺ T cell expansion, function, and secondary recall responses during persistent phagosomal infection.

Authors:  Abinav Kumar Singh; Nagaraja R Thirumalapura
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

Review 2.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

Review 3.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

Review 4.  T cell exhaustion during persistent viral infections.

Authors:  Shannon M Kahan; E John Wherry; Allan J Zajac
Journal:  Virology       Date:  2015-01-22       Impact factor: 3.616

5.  Too much of a good thing: Sustained type 1 interferon signaling limits humoral responses to secondary viral infection.

Authors:  John R Teijaro
Journal:  Eur J Immunol       Date:  2016-02       Impact factor: 5.532

6.  Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.

Authors:  Ivan Osokine; Laura M Snell; Cameron R Cunningham; Douglas H Yamada; Elizabeth B Wilson; Heidi J Elsaesser; Juan Carlos de la Torre; David Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

7.  Therapeutic depletion of natural killer cells controls persistent infection.

Authors:  Stephen N Waggoner; Keith A Daniels; Raymond M Welsh
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

Review 8.  Decoding the complexity of type I interferon to treat persistent viral infections.

Authors:  Elizabeth B Wilson; David G Brooks
Journal:  Trends Microbiol       Date:  2013-11-08       Impact factor: 17.079

9.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

10.  Overcoming CD4 Th1 Cell Fate Restrictions to Sustain Antiviral CD8 T Cells and Control Persistent Virus Infection.

Authors:  Laura M Snell; Ivan Osokine; Douglas H Yamada; Justin Rafael De la Fuente; Heidi J Elsaesser; David G Brooks
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.